The New York Times (NYT) has initiated a lawsuit against the European Commission, EC, for the release of text messages exchanged between the European Union’s top officials and Pfizer’s (PFE) CEO as they negotiated a multibillion-euro COVID-19 vaccine deal, Jenny Gross of The New York Times reports. At its core, this case is whether the text messages qualify as documents subject to transparency laws and could set a legal precedent.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NYT:
- New York Times tech workers set to end strike, Business Insider reports
- New York Times’ Striking Tech Guild Returns to Work as Negotiations Continue
- New York Times (NYSE:NYT) Receives Multiple Wall Street Upgrades
- New York Times price target raised to $66 from $65 at Deutsche Bank
- The New York Times Company Sees Strong Q3 2024 Growth